Suparma Tbk PT (SPMA)
IDX
148.00
-2.00 (-1.33%)
Closed
Nov 6, 2026
Day's Range
147.00150.00
52 wk Range
136.92223.67
Financial Statements - SPMA - Suparma Tbk PT
Revenue
2.74T▲ 0.4%
Net Income
106.23B▲ 1.3%Net Margin 3.9%
EBITDA
186.52B▲ 7.9%
Free Cash Flow
538.43B▼ 19.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 2.74T | 2.72T | 2.65T | 3.13T | 2.79T | 2.15T |
| Cost of Goods | 2.30T | 2.31T | 2.18T | 2.41T | 2.20T | 1.75T |
| Gross Profit | 434.43B | 412.84B | 470.61B | 718.75B | 589.15B | 392.78B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 199.35B | 190.33B | 255.06B | 526.30B | 412.68B | 229.06B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 136.73B | 134.44B | 237.84B | 431.44B | 377.50B | 195.50B |
| Income Tax | 30.50B | 29.60B | 59.19B | 95.30B | 83.18B | 32.97B |
| Net Income | 106.23B | 104.83B | 178.65B | 336.13B | 294.32B | 162.52B |
| EPS Basic | 20 | 25.384615 | 57 | 107 | 93 | 51.622419 |
| EPS Diluted | 20 | 25.384615 | 57 | 107 | 93 | 51.622419 |
| Basic Shares Outstanding | 5.33B | 4.10B | 3.15B | 3.15B | 3.15B | 3.15B |
| Diluted Shares Outstanding | 5.33B | 4.10B | 3.15B | 3.15B | 3.15B | 3.15B |
| Ebit | 176.42B | 169.36B | 272.47B | 463.86B | 408.62B | 228.81B |
| Ebitda | 186.52B | 172.94B | 276.92B | 468.22B | 420.78B | 232.08B |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
